.After antibody-drug conjugate (ADC) specialist Seagen was actually offered to Pfizer in 2014 for a ...
.On the heels of a stage 3 succeed that fell short to wow real estate investors, Ironwood Pharmaceut...
.Do not cease Monte Rosa Therapeutics now. The Boston-based biotech is enjoying after signing a deal...
.Invite to today's Chutes & Ladders, our summary of considerable leadership hirings, shootings an...
.Commemorating his business's upsized going public (IPO), Septerna chief executive officer Jeffrey F...
.AbbVie has come back to the source of its own antipsychotic powerhouse Vraylar in search of one mor...
.GenSight Biologics is actually weeks out of losing cash. Once again. The biotech simply has enough ...
.Monopar Therapies is actually recuperating a drug from the scrap heap of AstraZeneca's uncommon ail...
.With brand-new records out on Arcus Biosciences' speculative HIF-2a inhibitor, one team of experts ...
.After creating a genetics therapy relationship along with Dyno Rehabs in 2020, Roche is back for mo...